ASRPS, a lncORF-encoded peptide, is significantly downregulated in triple-negative breast cancer (TNBC) compared to other breast cancer subtypes, and low ASRPS expression is correlated with worse prognosis and overall survival in TNBC patients [16]. This evidence concerns the gene LINC00908 and breast carcinoma.